New research from a team at the University of California, Los Angeles (UCLA) has uncovered how fragments of the COVID-19 virus can specifically target and kill crucial immune cells in the body. This study, published in the Proceedings of the National Academy of Sciences, highlights the mechanisms through which these viral remnants can contribute to the depletion of immune defenses, particularly in severe cases of the disease.
The researchers demonstrated that when human immune enzymes break down the spike protein of the SARS-CoV-2 virus, certain resulting fragments can penetrate the membranes of specific immune cells. These fragments preferentially target and kill sentinel cells and T cells, both of which are crucial for the body’s immune response. The findings suggest a potential explanation for the depletion of these cells in patients suffering from severe COVID-19 symptoms.
Understanding the Impact of Viral Fragments
The UCLA-led research team, consisting of nearly three dozen experts from various fields including engineering, microbiology, and immunology, discovered that the fragments of the viral spike protein can interact with immune cells based on their shape. According to Gerard Wong, a professor of bioengineering at UCLA and co-corresponding author of the study, these fragments exploit specific membrane curvatures of immune cells to breach their defenses. This targeting mechanism is distinct from typical interactions seen between viruses and cell receptors.
The study’s co-author, Haleh Alimohamadi, explained that the fragments accumulate on the surface of activated immune cells, such as dendritic cells and T cells, which are already responding to the viral infection. By penetrating these cells, the fragments effectively suppress the body’s natural defenses. Wong noted that the depletion of these immune cells correlates with the severity of COVID-19, as doctors often monitor T cell counts in patients to assess disease progression.
Insights into the Omicron Variant
The research also explored the behavior of the omicron variant, which has been noted for its high transmissibility but generally milder symptoms. The team compared the effects of spike protein fragments from the omicron variant with those from earlier strains. Notably, the omicron fragments demonstrated significantly less activity against immune cells, suggesting that the immune system is less depleted in patients infected with this variant.
Yue Zhang, a former UCLA postdoctoral researcher now at Westlake University, emphasized the importance of these findings in understanding why omicron infections are often less severe. The fragments from the omicron variant destroyed only a small fraction of dendritic cells and had minimal impact on T cells.
The study highlights that no single viral fragment is solely responsible for the immune cell targeting; rather, the diverse nature of the protein fragments allows multiple variations to engage in this harmful activity. This complexity may explain why some individuals with preexisting inflammatory or autoimmune conditions experience more severe COVID-19 outcomes.
The researchers aim to continue their investigation into the impacts of SARS-CoV-2 protein fragments on the body, particularly concerning long-haul COVID and various health complications that arise post-infection. Wong remarked on the necessity of understanding not just how the virus replicates, but also how its remnants affect the body both during and after the infection.
The study received funding from several prestigious organizations, including the National Science Foundation and the National Institutes of Health, and included contributions from researchers across multiple countries, showcasing the global effort to understand and combat the COVID-19 pandemic.
